Human CD30/TNFRSF8 Antibody, R&D Systems™

CD30/TNFRSF8

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8

Mouse

Protein A or G purified from ascites

RUO

943

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot, Immunohistochemistry

81316

Western Blot 1 ug/mL, Immunohistochemistry 5-25 ug/mL

P28908

TNFRSF8

S. frugiperdainsect ovarian cell lineSf21-derived recombinant human CD30/TNFRSF8 Phe19-Lys379 Accession # P28908

500 μg

Primary

Detects human CD30/TNFRSF8 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) 4-1BB, rhCD27, recombinant mouse CD30, rhCD40, rhDR3, rhDR6, rhFas, rhGITR, rhHVEM, rhLT beta R, rhNGF R, rhOPG, rhRANK, rhTNF RI, or rhTNF RII is observed.

Human

Purified